AVROBIO, Inc. Gains 45.33%
Thu, May 18, 2023 at 07:44 PM
AVROBIO, Inc. (AVRO:NASDAQ) jumped higher at $0.84, a gain of 45.3%. On Thu, May 18, 2023, AVRO:NASDAQ hit a New 2-Week High of $0.84. The stock appeared on our News Catalysts scanner on Thu, May 18, 2023 at 04:00 PM in the 'BIOTECH' category. From Thu, May 04, 2023, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Fri, Feb 10, 2023 at $1.93 with a volume of 3M+.
About AVROBIO, Inc. (AVRO:NASDAQ)
Avrobio Inc is a clinical stage gene therapy company. It is engaged in the development of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.
Top 10 Gainers:
- Enveric Biosciences Inc. (ENVB:NASDAQ), 136.96%
- AVROBIO, Inc. (AVRO:NASDAQ), 45.33%
- Wang & Lee Group Inc. (WLGS:NASDAQ), 44.7%
- Sonder Holdings Inc. (SOND:NASDAQ), 41.37%
- Eltek Ltd. (ELTK:NASDAQ), 36.96%
- GSI Technology, Inc. (GSIT:NASDAQ), 35.78%
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 34.31%
- Cue Health Inc. (HLTH:NASDAQ), 29.72%
- Stryve Foods Inc. (SNAX:NASDAQ), 29.5%
- Urstadt Biddle Properties Inc. (UBP:NYSE), 28.44%